Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06840860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)

Study acronym: MBOTE-EPIC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Primary and study completion dates: Feb 2027 to Feb 28, 2027
    • Start date changed from estimate of Feb 2025 to Mar 28, 2025
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to better understand how mpox is spreading in the DRC, how it affects different groups of people, and how well vaccines protect against it. The study is designed as a cross-sectional survey, meaning researchers will collect and analyze data from patients diagnosed with mpox at a single point in time. It will also use a case-control approach, comparing people who test positive for the virus to those who test negative, to identify risk factors and evaluate the effectiveness of the vaccine.
Trial Details
NCT Number NCT06840860
Lead Sponsor Institute of Tropical Medicine, Belgium
Collaborators: University of Manitoba, Catholic University of Bukavu, Democratic Republic of Congo, University of Bern, Alliance for International Medical Action, Institut de Recherche pour le Developpement, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, European and Developing Countries Clinical Trials Partnership (EDCTP), University of California, Los Angeles
Conditions
(from sponsor)		 Monkeypox (Mpox)
Related terms DNA Virus Infections, Infections, Mpox, Monkeypox, Poxviridae Infections, Virus Diseases
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov